Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' SurveyTwo patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatment throughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment. Patients include:1) Elderly patient with good prognosis metastatic clear cell carcinoma2) Clear cell carcinoma and comorbiditiesData has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Metastatic Clear Cell Renal Cell Cancer. Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer. This report allows you to:' Understand what occurs with actual patients' Access the most up-to-date prescribing trends' Gain actionable data for developing and improving your market strategies' Pinpoint needs of your target audience' Focus resources to maximize the effectiveness of your budget' Understand where your product fits' Understand where your competitor's product fits' Design messages to advance brand performance
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a
US Oncologists' Survey
Published on February 2011
Report Summary
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey
Two patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic
Clear Cell Renal Cell Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatment
throughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment. Patients include:
1) Elderly patient with good prognosis metastatic clear cell carcinoma
2) Clear cell carcinoma and comorbidities
Data has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the
oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Metastatic Clear Cell Renal Cell
Cancer.
Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the
introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow
you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in
advanced stages of cancer.
This report allows you to:
' Understand what occurs with actual patients
' Access the most up-to-date prescribing trends
' Gain actionable data for developing and improving your market strategies
' Pinpoint needs of your target audience
' Focus resources to maximize the effectiveness of your budget
' Understand where your product fits
' Understand where your competitor's product fits
' Design messages to advance brand performance
Table of Content
Table of Contents
Executive Summary5
Chapter 1: Introduction7
Table 1. Treatment Options in Renal Cell Cancer7
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 1/4
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Chapter 2. Survey Respondent Demographics9
Table 2. Eligibility Criteria for Survey Participation9
Figure 2.1 Gender of Survey Respondents9
Figure 2.2 Years since Medical School Graduation10
Figure 2.3 Practice Settings10
Figure 2.4 Practices in NCI Cancer Centers11
Figure 2.5 Geographic Settings11
Figure 2.6 Survey Respondents by State's Renal Cell Cancer Mortality12
Figure 2.7 Number of Physicians in Practice Groups13
Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen13
Chapter 3: Treatment of an Elderly Patient with Metastatic Clear Cell Renal Cell Carcinoma14
Figure 3.1 Treatment Regimen Chosen Following Surgery14
Figure 3.2 Adding Therapeutic Agents with Initial Treatment15
Figure 3.3 Treatment Decision for Medication Toxicity16
Figure 3.4 Second-Line Therapy17
Figure 3.5 Factors Influencing Treatment18
Figure 3.6 Confidence in Managing Clear Cell Renal Cell Carcinoma19
Figure 3.8 Most Important Barrier to Optimal Patient Management21
Chapter 4. Treatment of a Patient with Metastatic Clear Cell Renal Cell Carcinoma with Comorbidities23
Figure 4.1 Management of Patient with Metastatic Disease and Comorbidities23
Figure 4.2 Choice of Systemic Therapy Agent24
Figure 4.3 Test to Monitor to Evaluate Increased Fatigue with Pazopanib25
Figure 4.4 Next Systemic Treatment Choice for Progressive Disease26
Chapter 5: Summary27
Appendix A: Survey Instrument28
Companies mentioned
Novartis, Genentech/Roche, Onyx/Bayer, Pfizer, GlaxoSmithKline, Amgen
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 2/4
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 499.00 Quantity: _____
CD-ROM--USD 2 499.00 Quantity: _____
Hard Copy--USD 2 499.00 Quantity: _____
Corporate License--USD 4 800.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 3/4
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 4/4